2021
DOI: 10.21037/tlcr-21-562
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma

Abstract: Background: Lung invasive mucinous adenocarcinoma (LIMA) is a unique and rare subtype of lung adenocarcinoma. We identified prognostic factors and developed a nomogram for predicting overall survival (OS) in LIMA patients after surgery. Methods: Patients diagnosed with LIMA between 2008 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) database were randomized into training (n=1,254) and test (n=538) cohorts. A nomogram was established using the prognostic signature from the training cohort … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 29 publications
0
11
0
Order By: Relevance
“…By including these factors in the model, the variability of patient data collection is minimized and the model's clinical usefulness is greatly increased. The use of an easy-to-use scoring system across a wide range of settings is more likely to improve the performance of clinical assessments (26). By incorporating these independent risk factors, we developed a nomogram that accurately predicts OS in patients with metastatic LUAD at 12, 24 and 36 months.…”
mentioning
confidence: 99%
“…By including these factors in the model, the variability of patient data collection is minimized and the model's clinical usefulness is greatly increased. The use of an easy-to-use scoring system across a wide range of settings is more likely to improve the performance of clinical assessments (26). By incorporating these independent risk factors, we developed a nomogram that accurately predicts OS in patients with metastatic LUAD at 12, 24 and 36 months.…”
mentioning
confidence: 99%
“…Still, they have failed to differentiate between local and radical resection and have not presented reliable postoperative prognostic models. Nomograms have been proved to have superior predictive accuracy than the current AJCC stage in previous analyses of prognostic cancer models after surgical resection, such as gastric cancer, lung cancer, cholangiocarcinoma, and other malignancies (35)(36)(37). To the best of our knowledge, this was the first study to establish and validate a prognostic nomogram that was not inferior to the AJCC staging system to predict 1-,3-and 5year OS for osteosarcoma patients after surgical resection.…”
Section: Discussionmentioning
confidence: 91%
“…While IMAs were regarded to present at an advanced stage during diagnosis and might not be treated by surgery, 10,25,26 a study that analyzed the Surveillance, Epidemiology, and End Results database reported a high proportion of up to 70% IMA in the early stages 27 . Most studies concerning the surgical outcome of IMA also included stage I or II rather than advanced stages 18,23,28,29 . In this study, the patient population comprised patients with stages I–II disease, and approximately 10% of patients had stage III disease.…”
Section: Discussionmentioning
confidence: 97%
“… 27 Most studies concerning the surgical outcome of IMA also included stage I or II rather than advanced stages. 18 , 23 , 28 , 29 In this study, the patient population comprised patients with stages I–II disease, and approximately 10% of patients had stage III disease. Due to this difference, the RFS and OS results were different from those of previous studies.…”
Section: Discussionmentioning
confidence: 99%